Atlas Trials

Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification

Clinical trial NCT02799173 · COMPLETED

Trial details

NCT number
NCT02799173
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
OsteoporosisLupus Erythematosus, Systemic
Start date
2011-04-15
Primary completion
2015-07-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.